SLP Logo

Simulations Plus, Inc. (SLP) 

NASDAQ
Market Cap
$598.2M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
384 of 774
Rank in Industry
14 of 32

Largest Insider Buys in Sector

SLP Stock Price History Chart

SLP Stock Performance

About Simulations Plus, Inc.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and …

Insider Activity of Simulations Plus, Inc.

Over the last 12 months, insiders at Simulations Plus, Inc. have bought $0 and sold $11.82M worth of Simulations Plus, Inc. stock.

On average, over the past 5 years, insiders at Simulations Plus, Inc. have bought $1.4M and sold $12.16M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 24,000 shares for transaction amount of $1.4M was made by WOLTOSZ WALTER S () on 2020‑08‑26.

List of Insider Buy and Sell Transactions, Simulations Plus, Inc.

2024-11-01Sale
20,000
0.0995%
$27.66$553,200+10.51%
2024-10-01Sale
20,000
0.1006%
$31.26$625,200-2.11%
2024-09-27Saledirector
750
0.0038%
$31.54$23,655-2.73%
2024-09-03Sale
20,000
0.1014%
$35.18$703,677-9.29%
2024-09-03Saledirector
650
0.0034%
$35.95$23,368-9.29%
2024-08-01Sale
20,000
0.0991%
$39.63$792,547-19.60%
2024-07-01Sale
20,000
0.098%
$46.71$934,2270.00%
2024-06-28Saledirector
750
0.0039%
$49.32$36,9900.00%
2024-06-03Sale
20,000
0.1006%
$46.25$924,978-24.53%
2024-06-03Saledirector
650
0.0034%
$48.26$31,369-24.53%
2024-05-14Saledirector
3,000
0.0152%
$50.13$150,390-26.14%
2024-05-14Saledirector
500
0.0025%
$50.00$25,000-26.14%
2024-05-07Saledirector
3,250
0.0163%
$48.31$157,008-24.11%
2024-05-07Saledirector
650
0.0033%
$48.30$31,395-24.11%
2024-05-01Sale
20,000
0.0993%
$45.95$918,984-20.34%
2024-04-01Sale
20,000
0.1004%
$39.94$798,867-0.68%
2024-03-01Sale
20,000
0.1%
$41.41$828,240+0.51%
2024-02-02Sale
1,055
0.005%
$37.64$39,710+9.93%
2024-02-01Sale
18,945
0.0915%
$38.02$720,237+9.24%
2024-01-04Saledirector
1,000
0.0053%
$43.74$43,740-0.96%

Insider Historical Profitability

70.82%
WOLTOSZ WALTER S
3462584
17.2549%
$29.81287+107.53%
WOLTOSZ VIRGINIA E
4097907
20.4209%
$29.81126+210.67%
D ARGENIO DAVID Z
33608
0.1675%
$29.8168+17.51%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$103.43M12.562.51M-1.15%-$1.2M<0.01
Conestoga Capital Advisors, LLC$93.15M11.312.26M+0.2%+$188,425.881.37
Neuberger Berman$53.52M6.51.3M-1.51%-$822,794.250.04
The Vanguard Group$46.71M5.671.14M+1.13%+$519,971.40<0.01
Ranger Investment Management L P$34.35M4.17834,828-10.34%-$3.96M2.25
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.